GLP-1 Drugs: 6 Things We’ve Learned About Their Effects
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
Search fresh public links, source activity, and ready-to-use post angles for Glp‑1 Drugs.
Fresh curated links around GLP‑1 drugs are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
The widespread use of drugs like Ozempic is giving scientists a clearer picture than ever of their effects.
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. "GLP-1 receptor agonists have never been just glucose-lower...
A huge international review found that GLP-1 weight-loss drugs significantly reduce the risk of heart attacks, strokes, heart failure, and premature death over the long term. Resea...
GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology’s annual me...
What started as a diabetes medication has rapidly become one of the most talked-about drug categories in modern medicine. GLP-1 medications such as Ozempic, Wegovy,...
Recent studies suggest the weight loss and diabetes drugs may prevent cancer and slow its progression. While weight loss is known to curb cancer risks, GLP-1s may act on other brai...
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...
Eli Lilly makes the best-selling GLP-1 drug, and sales are accelerating.
GLP-1 medications and hormone therapies have moved from niche to mainstream. About 19% of large employers now cover GLP-1 drugs used primarily for weight loss, according to the Kai...
GLP-1 medications have exploded in popularity over the past few years, and it’s easy to see why. They work. People lose significant weight, blood sugar improves, and for the first...
GLP-1 medications are marketed to help you lose weight, but one may be better at it than the rest, researchers report.
A massive study of more than 600,000 U.S. veterans suggests that popular GLP-1 drugs such as semaglutide may do far more than help with diabetes and weight loss—they could also fig...
Use of GLP-1s was associated with significantly reduced risk for hepatic complications among patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabe...
New research links GLP-1 drugs to reduced cancer risk across several types, though experts say more studies are needed.
THURSDAY, July 9, 2026 — The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. That’s about 40 million people — as many folks who live in Calif...
Currently, two generic versions of Ozempic and Wegovy are available for Canadians to purchase for patients who use it to treat diabetes or weight loss for a fraction of the cost.
GLP-1 drugs like Ozempic and Wegovy may reduce cancer risk by up to 58%, outperforming diet and exercise alone The post GLP-1 Drugs Like Ozempic May Cut Cancer Risk Up to 58% appea...
The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide...
A new wave of research links GLP-1 drugs to reduced cancer spread and better survival, and the mechanism may go beyond just weight loss
A new study found that some cancer patients who took GLP-1 drugs saw some remission — especially if they had breast cancer.
A new oral GLP-1 medication helped people with type 2 diabetes dramatically improve blood sugar control and lose weight in a major clinical trial. The results suggest that highly e...
Sold under brand names like Wegovy and Ozempic, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become a popular way to curb appetite and lose weight.Continue ReadingCat...
NEW ORLEANS — Individuals with obesity and autoimmune diseases who use a GLP-1 receptor agonist may have lower risk for mortality, fewer cardiovascular and thrombotic events and lo...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.